341 related articles for article (PubMed ID: 19667950)
21. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
[TBL] [Abstract][Full Text] [Related]
22. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
[TBL] [Abstract][Full Text] [Related]
23. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
[TBL] [Abstract][Full Text] [Related]
24. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
[TBL] [Abstract][Full Text] [Related]
25. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
[TBL] [Abstract][Full Text] [Related]
26. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
27. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
[TBL] [Abstract][Full Text] [Related]
28. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
[TBL] [Abstract][Full Text] [Related]
29. Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors.
San Segundo D; Fábrega E; López-Hoyos M; Pons F
Transplant Proc; 2007 Sep; 39(7):2290-2. PubMed ID: 17889166
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period.
Kim SH; Oh EJ; Ghee JY; Song HK; Han DH; Yoon HE; Choi BS; Yoon SK; Choi JY; Moon IS; Kim DG; Yang CW
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S135-42. PubMed ID: 19194543
[TBL] [Abstract][Full Text] [Related]
31. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study.
Zhao T; Yang C; Qiu Y; Xue Y; Zhao Z; Song D; Qiu Y; Ma Z; Yang B; Xu M; Rong R; Zhu T
Transplant Proc; 2013; 45(1):148-52. PubMed ID: 23375289
[TBL] [Abstract][Full Text] [Related]
32. Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy.
Chen J; Li L; Wen J; Tang Z; Ji S; Sha G; Cheng Z; Sun Q; Cheng D; Liu Z
Transplant Proc; 2008 Jun; 40(5):1411-5. PubMed ID: 18589119
[TBL] [Abstract][Full Text] [Related]
33. Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.
Hsu KH; Chou NK; Tsai MK; Chi NH; Chen YS; Yu HY; Wang CH; Ko WJ; Tsao CI; Lee PH; Wang SS
Transplant Proc; 2010 Apr; 42(3):934-7. PubMed ID: 20430208
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil.
Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N
Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536
[TBL] [Abstract][Full Text] [Related]
35. Deferred pre-emptive switch from calcineurin inhibitor to sirolimus leads to improvement in GFR and expansion of T regulatory cell population: a randomized, controlled trial.
Bansal D; Yadav AK; Kumar V; Minz M; Sakhuja V; Jha V
PLoS One; 2013; 8(10):e75591. PubMed ID: 24146762
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P; Perico N; Gotti E; Cravedi P; D'Agati V; Gagliardini E; Abbate M; Gaspari F; Cattaneo D; Noris M; Casiraghi F; Todeschini M; Cugini D; Conti S; Remuzzi G
Transplantation; 2007 Oct; 84(8):956-64. PubMed ID: 17989600
[TBL] [Abstract][Full Text] [Related]
38. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
[TBL] [Abstract][Full Text] [Related]
39. Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion.
Cavinato RA; Casiraghi F; Azzollini N; Mister M; Pezzotta A; Cassis P; Cugini D; Perico N; Remuzzi G; Noris M
Kidney Int; 2007 Jun; 71(11):1132-41. PubMed ID: 17377507
[TBL] [Abstract][Full Text] [Related]
40. CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation.
Li Y; Shi Y; Huang Z; Bai Y; Niu Q; Cai B; Wang L; Feng W
Int Immunopharmacol; 2011 Dec; 11(12):2033-8. PubMed ID: 21911083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
